ResMed Inc.
Michael J. Farrell (Chairman and CEO) reports RMD insider transactions
AI-generated summary
Michael J. Farrell, Chairman and CEO, Director of ResMed Inc., had 8,111.385 shares withheld for taxes at an average price of $234.11, valued at $1,898,956.34. After these transactions, the insider directly held 471,774 shares.
Key facts
- Insider
- Michael J. Farrell · Chairman and CEO, Director
| Date | Transaction | Shares | Price | Value | Held after | Ownership |
|---|---|---|---|---|---|---|
| Nov 11, 2026 | F · tax withholdingFootnotes F1 | −3,465.749 | $234.11 | $811,366.50 | 476,419 | Direct |
| Nov 11, 2026 | F · tax withholdingFootnotes F2 | −2,209.793 | $234.11 | $517,334.64 | 474,209 | Direct |
| Nov 11, 2026 | F · tax withholdingFootnotes F3, F4 | −2,435.843 | $234.11 | $570,255.20 | 471,774 | Direct |
Footnotes
- F1 Disposition to issuer for tax withholding on vesting of Restricted Stock Units granted on 11/16/2023.
- F2 Disposition to issuer for tax withholding on vesting of Restricted Stock Units granted on 11/20/2024.
- F3 Disposition to issuer for tax withholding on vesting of Restricted Stock Units granted on 11/20/2025.
- F4 Includes 82.2684 shares of Resmed stock purchased on Oct 30, 2026 through the Resmed Employee Stock Purchase Plan.
More RMD filings
- 4
Filed Nov 13, 2026
- 4
Filed Nov 13, 2026
- 4
Filed Nov 13, 2026
- 4
Filed Nov 13, 2026
- 4
Filed Nov 13, 2026
- 4
Filed Nov 12, 2026
Not investment advice. Summaries can contain errors; the SEC filing is the official record.